I am a board-certified Medical Physicist and Assistant Professor in the Department of Human Oncology at the University of Wisconsin–Madison. My primary focus is on educational initiatives, and I serve as the Director of the Medical Physics Residency program. I have a passion for teaching and sharing the fun world of medical physics with residents, students, and whoever else I am able to share my excitement with. I am also involved in helping improve medical physics education on the national level though committees within the AAPM, SDAMPP, CEMPEP, and ABR organizations.
My clinical work focuses on adaptive and MR-guided radiotherapy through my work with the ViewRay MRIdian system. This system gives us the opportunity, via MR imaging, to adapt the patient’s radiation plan to their anatomy on the day of treatment and enables us to visualize the anatomy throughout treatment. In addition to my clinical work on the ViewRay system, I have a strong interest in increasing automation throughout the clinic to streamline workflows. My research has primarily focused on patient safety and quality management, including analysis of trends and investigation of workflow inefficiencies.
I am an assistant professor and board-certified medical physicist in the Department of Human Oncology at the University of Wisconsin – Madison. My clinical sub-specialty is brachytherapy. I also provide general physics support across the Department.
I am a medical physicist board-certified in radiation oncology in both the U.K., where I did my initial training, and the U.S. My primary focus is ensuring that patient treatments are executed correctly and safely through comprehensive review of radiation treatment plans and quality assurance of the treatment machines used to deliver radiation. I am also focused on providing physics support for clinical trial execution and data management within the Department of Human Oncology.
The Zhao Lab focuses on developing novel clinical biomarkers that predict response and resistance to specific therapies across cancers. These biomarkers can be used to better select which patients derive a benefit from treatment, which patients do not and can be spared potential toxicity, as well as monitor for emergence of resistance. It seeks to use advanced computational approaches and liquid biopsy technologies to better personalize the care of cancer patients.
Carri Glide-Hurst, PhD, DABR, FAAPM is a tenured Associate Professor in the Department of Human Oncology and member of the UW Carbone Cancer Center. She serves as the Director of Radiation Oncology Physics and Bhudatt Paliwal Endowed Professor at the University of Wisconsin. Dr. Glide-Hurst obtained a PhD in Medical Physics from Wayne State University with an emphasis on evaluating breast density, a known risk factor for breast cancer, using ultrasound tomography.
Clinically, Dr. Floberg focuses on the treatment of genitourinary cancers. As a radiation oncologist, he collaborates with urologists, medical oncologists, radiologists, pathologists and other specialists to provide patients with the best care possible.
Dr. Cosper’s main interest is in Human Papilloma Virus (HPV) induced cancers, such as cervical and head and neck cancer. Specifically, she is interested in how the virus induces different types of chromosomal instability (CIN) and how this affects radiation sensitivity, which may offer some insight into radiation sensitivity or resistance within HPV+ cancers.